Skip to main content

𝙇𝙑𝙃 𝙀𝙣 π™€π˜Ύπ™‚ – 𝙏𝙬𝙀 π˜½π™šπ™¨π™© π™ˆπ™šπ™©π™π™€π™™π™¨





Left Ventricular Hypertrophy (LVH) is a common finding in patients with long-standing hypertension, aortic stenosis, or other conditions that increase left ventricular workload. Detecting LVH on an electrocardiogram (ECG) is crucial for identifying cardiac remodeling before structural heart disease becomes advanced. Although echocardiography remains the gold standard, ECG provides a fast and cost-effective screening tool.


---

What is LVH?

LVH refers to thickening of the left ventricular wall due to chronic pressure overload. On ECG, this manifests as increased QRS voltage and often secondary repolarization (strain) changes in the lateral leads.


---

Main ECG Criteria for LVH

1. Sokolow–Lyon Criteria

One of the oldest and simplest ECG criteria for LVH, mainly based on precordial lead voltages.

Formula:

S in V1 + R in V5 or V6 ≥ 35 mm (3.5 mV)
(Use the larger R wave between V5 and V6)


Optional additional criterion:

R in aVL ≥ 11 mm


Key Features:

Easy and quick to apply.

Best used in young, thin patients.

May overestimate LVH in lean individuals and underestimate it in obese or elderly patients.

Does not account for gender or age differences.




2. Cornell Criteria

Developed to improve the accuracy of voltage-based LVH detection by including both limb and chest leads, with adjustments for sex.

Formula:

R in aVL + S in V3 > 28 mm (men)

R in aVL + S in V3 > 20 mm (women)


Key Features:

More specific than Sokolow–Lyon.

Accounts for body and gender differences.

Reliable for both limb and chest lead analysis.

Cornell Voltage–Duration Product enhances accuracy:
(R in aVL + S in V3) × QRS duration > 2440 mm·ms indicates LVH.

---

Other Supportive ECG Findings

Left axis deviation

Left atrial enlargement

ST segment depression and T-wave inversion (“strain pattern”) in lateral leads

Prolonged QRS duration


These findings reinforce the suspicion of LVH but are not diagnostic by themselves.


---

Clinical Significance

LVH on ECG is not just a voltage change—it is a marker of cardiac risk. Patients with ECG evidence of LVH have higher rates of arrhythmia, heart failure, and sudden cardiac death. Recognizing it early allows for timely control of hypertension and other contributing factors.

---

Takeaway:
ECG remains an invaluable first step in detecting LVH. The Sokolow–Lyon criterion is simple and traditional, while the Cornell criterion offers better accuracy and clinical reliability. Confirm findings with echocardiography, and always interpret ECG voltages in the context of the patient’s body build and clinical history.


---

#LVH #ECG #SokolowLyon #CornellCriteria #Cardiology #Hypertension #HeartHealth #Electrocardiogram #CardiacRisk #Echo


Thanks 😊 

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.